Pharma & Biotech

Today marks a critical juncture for BioNTech as the German biotech firm unveils its strategic roadmap in New York. Investors...

In an investment landscape captivated by technological transformation, market participants are perpetually searching for the next frontier of expansion. Two...

Aclaris Therapeutics witnessed a significant selloff in its stock price after releasing disappointing third-quarter 2025 financial results. The biotechnology firm...

Investor attention is focused on BioAtla Inc following the release of compelling clinical trial results for its lead oncology asset,...

Protara Therapeutics, a clinical-stage biotechnology firm, delivered an impressive quarterly performance that has reignited market interest. The company not only...

The medical technology firm TransMedics continues to post impressive operational results, yet its share price tells a conflicting story. Despite...

The biotechnology sector has a standout performer demonstrating how strategic achievements and impressive quarterly results can propel equity values to...

The pharmaceutical giant from Indianapolis is experiencing an exceptional period in the markets, propelled by a powerful combination of analyst...

Pacific Biosciences shares are demonstrating significant momentum in today's trading session, propelled by a landmark regulatory achievement in China that...

While Ocugen's latest financial results showed continued losses, market participants are focusing squarely on the company's advancing clinical programs. The...